Opportunities for European pharmaceutical and biotechnology companies in Indian and Chinese markets

Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies. Even as emerging markets such as Brazil, Mexico, Poland and Russia exhibit strong development potential, the most exciting growth prospects are forecast for two Asian powerhouses - India and China
read more: http://healthcare.frost.com

Comments

Popular posts from this blog

Amsterdam to Host EU Drug Agency

Early Intervention in Unstable CAD

Inflammatory Bowel Disease an Independent Risk Factor for MI